June 22, 2018 7:46 AM ET

Biotechnology

Company Overview of C4 Therapeutics, Inc.

Key Executives for C4 Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Andrew Phillips No RelationshipsPresident & CEO--
Kenneth C. Anderson M.D.148 RelationshipsCo-Founder and Member of Scientific Advisory Board66
James E. Bradner M.D.15 RelationshipsFounder45
Marc A. Cohen 41 RelationshipsCo-Founder and Executive Chairman54
Nathanael S. Gray 41 RelationshipsCo-Founder and Member of Scientific Advisory Board--
View More Key Executives

C4 Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Marc A. Cohen 41 RelationshipsBublup Inc.54
Kenneth C. Anderson M.D. 148 RelationshipsOncoPep, Inc.66
Nathanael S. Gray 41 RelationshipsSyros Pharmaceuticals, Inc.--
Christopher J. Kirk 23 RelationshipsKaryopharm Therapeutics Inc.--
Eric Fischer Ph.D. 6 RelationshipsC4 Therapeutics, Inc.--
View All Board Members

C4 Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
444.7K
Bonus
267.1K
Total Short Term Compensation
412.4K
Total Value of Options
14.2M
Compensation as of Fiscal Year
C4 Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Tracon Pharmaceuticals, Inc. Announces Executive Changes
June 15, 2018 8:54 PM ET
RenovaCare, Inc. Announces Executive Changes
June 15, 2018 6:05 PM ET
Athenex, Inc. Appoints Benson Tsang to the Board of Directors, Effective July 1, 2018 and as the Chairman of the Audit and Risk Management Committee as Well as a Member of the Nominating and Corporate Governance Committee
June 15, 2018 11:00 AM ET
Selecta Biosciences, Inc. Announces Resignation of Earl Sands as Chief Medical Officer
June 15, 2018 10:01 AM ET
MiMedx Group, Inc. Appoints John D. Harris as its Senior Vice President of International
June 15, 2018 12:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact C4 Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.